Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of drug targeting (Print)

• Publication date

  2011-06-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3109/1061186X.2010.523787PMID 20958095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats

  2010cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• Delivery of testosterone to the brain by intranasal administration: Comparison to intravenous testosterone

  2009cited by this paper
• Nanoparticles for direct nose-to-brain delivery of drugs.

  2009cited by this paper
• Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity.

  2008cited by this paper
• Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.

  2008cited by this paper
• Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride.

  2008cited by this paper
• Formulation and Targeting Efficiency of Cisplatin Engineered Solid Lipid Nanoparticles

  2008cited by this paper
• Solid lipid nanoparticles for targeted brain drug delivery.

  2007cited by this paper
• Effects of (-)stepholidine in animal models for schizophrenia

  2006influential reference
• Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?

  2006cited by this paper
• Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.

  2006cited by this paper
• Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLC

  2006cited by this paper
• Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.

  2005cited by this paper
• The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein.

  2004cited by this paper
• The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs

  2004cited by this paper
• In Situ Blood–Brain Barrier Transport of Nanoparticles

  2003cited by this paper
• Preparation and Characterization of Solid Lipid Nanoparticles Containing Cloricromene

  2003cited by this paper
• Systematic characterization of oil-in-water emulsions for formulation design.

  2003cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Choosing an atypical antipsychotic.

  2002cited by this paper
• Solid lipid nanoparticles: production, characterization and applications.

  2001cited by this paper
• Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

  2000cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.

  1999cited by this paper
• Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.

  1999influential reference
• Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?

  1998cited by this paper
• A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin

  1996cited by this paper
• Physics and Radiobiology of Nuclear Medicine

  1993cited by this paper

• Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration

  2025cites this paper
• Can nanoparticle-based intranasal delivery systems revolutionize treatment of central nervous system diseases?

  2025cites this paper
• Intranasal nanoparticulate drug delivery systems for neurodegenerative disorders: an Overview

  2025cites this paper
• Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy.

  2025cites this paper
• Gellan Gum-Based In Situ Hydrogels for Nasal Delivery of Polymeric Micelles Loaded with Risperidone

  2025cites this paper
• Maximising olfactory deposition of a valproic acid (VPA)-loaded nanostructured lipid carriers (NLC) formulation.

  2025cites this paper
• Design and optimization of intranasal aripiprazole-loaded nanostructured lipid carriers for enhanced brain targeting in schizophrenia: in vitro and ex vivo evaluation

  2025cites this paper
• Engineering Liposomes for Neurodegenerative Diseases: Targeted Delivery and Regenerative Potential

  2025cites this paper
• Advanced nanoparticle-enabled risperidone delivery for improved therapeutic outcomes of schizophrenia management: a review

  2025influential citation
• An Emerging Prospective of Antipsychotics for Treating Neurodegenerative Disorders.

  2025cites this paper
• Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature

  2024cites this paper
• Quality by design approach for development and characterization of gabapentin-loaded solid lipid nanoparticles for intranasal delivery: In vitro, ex vivo, and histopathological evaluation

  2024cites this paper
• Nanomedicine revolutionizes epilepsy treatment: overcoming therapeutic hurdles with nanoscale solutions

  2024cites this paper
• Advancement in the nose-to-brain drug delivery of FDA-approved drugs for the better management of depression and psychiatric disorders.

  2024cites this paper
• Development, Statistical Optimization, and Characterization of Resveratrol-Containing Solid Lipid Nanoparticles (SLNs) and Determination of the Efficacy in Reducing Neurodegenerative Symptoms Related to Alzheimer's Disease: In Vitro and In Vivo Study

  2024cites this paper
• Risperidone-Loaded Nasal Thermosensitive Polymeric Micelles: Quality by Design-Based Formulation Study

  2024cites this paper
• Recent progress in nanoparticulate-based intranasal delivery for treating of different central nervous system diseases

  2024cites this paper
• Intranasal delivery of sulpiride nanostructured lipid carrier to central nervous system; in vitro characterization and in vivo study

  2024cites this paper
• Unlocking the Blood-Brain Barrier for Enhanced Curcumin Delivery Using PEGylated Mesoporous Silica Nanoparticles

  2024cites this paper
• Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose-Brain Drug Delivery.

  2024cites this paper
• Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders

  2024cites this paper
• Exploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis

  2024cites this paper
• Neuroprotective effect of nose-to-brain delivery of Asiatic acid in solid lipid nanoparticles and its mechanisms against memory dysfunction induced by Amyloid Beta1-42 in mice

  2023cites this paper
• Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery

  2023cites this paper
• Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management

  2023cites this paper
• SOLID LIPID NANOPARTILCES: MODERN PROGRESS IN NOSE-TO-BRAIN TRANSDUCTION

  2023cites this paper
• Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs

  2023cites this paper
• Exploring the potential to enhance drug distribution in the brain subregion via intranasal delivery of nanoemulsion in combination with borneol as a guider

  2023cites this paper
• Radiolabeled Risperidone microSPECT/CT Imaging for Intranasal Implant Studies Development

  2023cites this paper
• Development of intranasal implantable devices for schizophrenia treatment.

  2022cites this paper
• Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs

  2022cites this paper
• Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery

  2022influential citation
• A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration.

  2022cites this paper
• Fabrication and Characterization of Clozapine Nanoemulsion Sol-Gel for Intranasal Administration.

  2022cites this paper
• Nanoparticles-based delivery system and its potentials in treating central nervous system disorders

  2022cites this paper
• Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations.

  2022cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Augmented Brain Delivery of Cinnarizine Through Nanostructured Lipid Carriers Loaded in situ Gel: in vitro and Pharmacokinetic Evaluation

  2021cites this paper
• Nano-lipidic formulation and therapeutic strategies for Alzheimer’s disease via intranasal route

  2021cites this paper
• Brain Targeting Through Intranasal Route: An Overview

  2021cites this paper
• Intranasal solid lipid nanoparticles for management of pain:A full factorial design approach, characterization& Gamma Scintigraphy.

  2021cites this paper
• Experimental models for evaluation of direct nose-to-brain drug delivery

  2021cites this paper
• NOSE TO BRAIN DELIVERY: ROLE OF VIRAL AND NON-VIRAL VECTORS FOR NEUROLOGICAL DISORDER

  2021cites this paper
• Development of mitochondrial targeted theranostic nanocarriers for treatment of gliomas

  2021cites this paper
• Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study

  2021cites this paper
• The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery.

  2021cites this paper
• OPTIMIZATION AND CHARACTERIZATION OF DOXORUBICIN LOADED SOLID LIPID NANOSUSPENSION FOR NOSE TO BRAIN DELIVERY USING DESIGN EXPERT SOFTWARE

  2021cites this paper
• Augmented Brain Delivery of Cinnarizine Through Nanostructured Lipid Carriers Loaded in situ Gel: in vitro and Pharmacokinetic Evaluation

  2021cites this paper
• The effects of silver nanoparticle shape on protein adsorption and neural stem cell viability

  2021cites this paper
• In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin

  2021cites this paper
• Nanoparticles Administered through Nasal Cavity and Its Progress in the Treatment of Brain Diseases

  2021cites this paper
• Using PCG-Arginine nanoparticle mediated intranasal delivery of dynorphin A (1–8) to improve neuroprotection in MCAO rats

  2021cites this paper
• Chitosan nanoparticles biosynthesis and characterization for Inhalation as an operative treatment of tuberculosis

  2021cites this paper
• Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood-Brain Barrier Transmitters.

  2021cites this paper
• Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier

  2021cites this paper
• Microemulsion as a promising carrier for nose to brain delivery: journey since last decade

  2021cites this paper
• New Insights into Nanoparticulate Carriers for Direct Nose‐to‐Brain Drug Delivery

  2021cites this paper
• Aerosolized In Vivo 3D Localization of Nose-to-Brain Nanocarrier Delivery Using Multimodality Neuroimaging in a Rat Model—Protocol Development

  2021cites this paper
• Intranasal route: The green corridor for Alzheimer's disease therapeutics

  2021cites this paper
• Multivesicular liposomal depot system for sustained delivery of risperidone: development, characterization, and toxicity assessment

  2021cites this paper
• Gel incorporated lipid nanoparticles for the treatment of psoriasis

  2021cites this paper
• Applications of innovative technologies to the delivery of antipsychotics.

  2021cites this paper
• Nanomedicines for Brain Drug Delivery

  2021cites this paper
• Nose-to-Brain Drug Delivery Enabled by Nanocarriers

  2020cites this paper
• Preparation, Statistical Optimization and In-vitro Characterization of a Dry Powder Inhaler (DPI) Containing Solid Lipid Nanoparticles Encapsulating Amphotericin B: Ion Paired Complexes with Distearoyl Phosphatidylglycerol

  2020cites this paper
• TARGETABLE MULTI-DRUG NANOPARTICLES FOR TREATMENT OF GLIOBLASTOMA WITH NEUROIMAGING ASSESSMENT

  2020cites this paper
• Review Imaging of intranasal drug delivery to the brain

  2020cites this paper
• Optimization of Solid Lipid Nanoparticles of Ezetimibe in Combination with Simvastatin Using Quality by Design (QbD)

  2020cites this paper
• Controlled Parenteral Formulations: An Efficacious and Favourable Way to Deliver the Anti-psychotic Drugs

  2020cites this paper
• Imaging of intranasal drug delivery to the brain.

  2020cites this paper
• Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule.

  2020cites this paper
• A comprehensive review of nano drug delivery system in the treatment of CNS disorders

  2020cites this paper
• Nose-to-brain delivery of antipsychotics using nanotechnology: a review

  2020cites this paper
• "Schizophrenia; a review on promising drug delivery systems".

  2020cites this paper
• Neuroprotection by curcumin: a review on brain delivery strategies.

  2020cites this paper
• Recent advances in the development of asenapine formulations

  2020cites this paper
• Challenges in oral drug delivery and applications of lipid nanoparticles as potent oral drug carriers for managing cardiovascular risk factors.

  2020cites this paper
• Nose-to-Brain Delivery of Diazepam from an Intranasal Aqua-Triggered In-Situ (ATIS) Gelling Microemulsion: Monitoring Brain Uptake by Microdialysis

  2020cites this paper
• Recent advances in polymeric and solid lipid–based nanoparticles for controlled drug delivery

  2020cites this paper
• Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations

  2020cites this paper
• Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy.

  2020cites this paper
• Patient-Friendly, Olfactory-Targeted, Stimuli-Responsive Hydrogels for Cerebral Degenerative Disorders Ensured > 400% Brain Targeting Efficiency in Rats

  2020cites this paper
• Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Emerging Lipid Based Drug Delivery Systems

  2019cites this paper
• Analyzing Nanotheraputics Based Approaches For The Management Of Psychotic Disorders.

  2019cites this paper
• α-Helical cell-penetrating peptide-mediated nasal delivery of resveratrol for inhibition of epithelial-to-mesenchymal transition.

  2019cites this paper
• Drug delivery to the brain

  2019cites this paper
• Surface Modification of Nanoparticles for Targeted Drug Delivery

  2019cites this paper
• Approaches for CNS delivery of drugs – nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment

  2019cites this paper
• A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders.

  2019cites this paper
• Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles.

  2019cites this paper
• Surface-Functionalized Lipid Nanoparticles for Site-Specific Drug Delivery

  2019cites this paper
• Formulating SLN and NLC as innovative drug delivery systems for non-invasive routes of drug administration.

  2019cites this paper
• Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics

  2018cites this paper
• Superparamagnetic Iron Oxide-Loaded Lipid Nanocarriers Incorporated in Thermosensitive In Situ Gel for Magnetic Brain Targeting of Clonazepam.

  2018cites this paper
• Evaluation of intranasal delivery route of drug administration for brain targeting.

  2018cites this paper
• Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages

  2018cites this paper
• A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers

  2018cites this paper
• Nanosystems in nose‐to‐brain drug delivery: A review of non‐clinical brain targeting studies

  2018cites this paper
• Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery

  2018cites this paper
• Attenuation of neurobehavioral and neurochemical abnormalities in animal model of cognitive deficits of Alzheimer’s disease by fermented soybean nanonutraceutical

  2018cites this paper